Filing Details

Accession Number:
0001127602-23-023824
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-06 18:06:49
Reporting Period:
2023-09-01
Accepted Time:
2023-09-06 18:06:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875045 Biogen Inc. BIIB Biological Products, (No Disgnostic Substances) (2836) 330112644
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1769608 Priya Singhal 225 Binney
Cambridge MA 02142
Head Of Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-01 1,668 $0.00 4,592 No 4 M Direct
Common Stock Disposition 2023-09-01 807 $267.17 3,785 No 4 F Direct
Common Stock Disposition 2023-09-05 431 $269.43 3,354 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2023-09-01 1,668 $0.00 1,668 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,337 2025-09-01 No 4 M Direct
Footnotes
  1. This award was granted to the reporting person on September 1, 2022 and will vest in three equal installments on each anniversary of the grant date.